Legal Status Overview
Gray AreaPeptides are legal in Oregon only when they are FDA-approved prescription drugs (such as branded semaglutide/tirzepatide or prescription human growth hormone) dispensed by an Oregon-licensed pharmacy; unapproved peptides sold as "research chemicals" occupy a legal gray zone with no Oregon statute naming them as a distinct category. Oregon's Board of Pharmacy regulates all drug compounding under Oregon Revised Statutes Chapter 689 and Oregon Administrative Rules Chapter 855, which incorporate the federal 503A/503B compounding framework rather than creating separate peptide rules. The Board has issued a specific position statement warning that compounding semaglutide and other GLP-1 peptides outside FDA/USP rules can trigger enforcement action, and federal FDA action has separately barred BPC-157 from compounding nationwide. No Oregon-specific bill, administrative rule, or attorney general opinion naming peptides or research chemicals as their own category was found in this research.
Key Points
- Oregon has no statute or administrative rule that names "peptides," "research chemicals," or research-use-only compounds as their own legal category; peptide legality in Oregon is governed by general Oregon pharmacy/compounding law layered on top of federal FDA drug law. [1]
- The Oregon Board of Pharmacy regulates all drug compounding, including peptide-based products, under Oregon Administrative Rules Chapter 855 (Divisions 45/183), which require compounders to register as drug outlets and follow the federal 503A (patient-specific pharmacy) or 503B (FDA-registered outsourcing facility) frameworks. [4]
- The Oregon Board of Pharmacy's Semaglutide Position Statement warns that compounding semaglutide and other GLP-1 receptor agonists in a way that fails to conform with governing law, or dispensing such non-conforming products, may lead to Board enforcement action. [5]
- An Oregon-licensed pharmacy compounding semaglutide or a similar GLP-1 peptide must ensure any active pharmaceutical ingredient is pharmaceutical-grade, accompanied by a valid certificate of analysis, and sourced from an FDA-registered establishment under section 510 of the FD&C Act, per Oregon Board of Pharmacy and Oregon Medical Board guidance. [6]
- A person cannot legally buy or import unapproved research peptides like BPC-157 or TB-500 for human use in Oregon because the FDA has banned BPC-157 from compounding nationwide over safety concerns and no Oregon exception exists for personal use or importation of such products. [7]
- Oregon-licensed 503A pharmacies and the state's single FDA-registered 503B outsourcing facility may compound peptide-class drugs such as semaglutide or tirzepatide only when a prescription meets the patient-specific clinical-need standard, since both drugs were removed from the FDA's national drug shortage list in late 2024/early 2025, ending the shortage-based legal basis for broad compounding. [9]
- No Oregon-specific legislation, bill, or attorney general opinion addressing peptides, research chemicals, or compounded GLP-1-class drugs as a distinct category was identified in the past several legislative sessions after searching Oregon legislative bill-tracking sources. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
Peptide-by-peptide status in Oregon
| BPC-157 | BPC-157 is not legal for human use or compounding in Oregon because the FDA formally banned the peptide from compounding nationwide in 2023 over undisclosed safety concerns, and it has no Oregon-specific exception or FDA approval as a drug. [7] |
|---|---|
| Semaglutide / Tirzepatide (GLP-1 class) | Branded semaglutide and tirzepatide products (e.g., Ozempic, Wegovy, Mounjaro, Zepbound) are legal in Oregon only by prescription through a licensed pharmacy, while compounded versions are now largely unlawful for Oregon 503A/503B pharmacies to make since the FDA declared the tirzepatide and semaglutide shortages resolved in late 2024 and February 2025 respectively, ending the shortage-based legal basis for compounding. [9] |
| TB-500 | TB-500 has no FDA approval and no Oregon-specific rule addressing it, so it falls into the same unregulated "research chemical" gray zone as BPC-157: not a scheduled controlled substance in Oregon, but not lawfully marketable, compoundable, or dispensable for human use by an Oregon pharmacy. [1] |
| Human Growth Hormone (HGH/somatropin) | Prescription HGH products are legal in Oregon when dispensed under a valid prescription for an FDA-approved indication through a licensed pharmacy, while distribution or possession with intent to distribute HGH for non-FDA-authorized uses (such as bodybuilding or anti-aging) is treated as a federal felony under 21 U.S.C. 333(e), a restriction that applies regardless of state. [10] |
Sources
Last researched: 2026-09-09
Frequently asked questions
Can I buy peptides in Oregon without a prescription?
No—FDA-approved peptide drugs such as branded semaglutide or prescription HGH require a valid prescription filled at an Oregon-licensed pharmacy, and unapproved "research use only" peptides like BPC-157 or TB-500 cannot be lawfully sold or marketed for human use in Oregon regardless of labeling. [1]
Is it legal to import research peptides into Oregon for personal use?
Oregon has no specific personal-importation allowance for unapproved research peptides, and because products like BPC-157 and TB-500 are unapproved new drugs under federal law rather than state-scheduled controlled substances, importing them for personal human use runs into federal FDA drug-approval requirements rather than any distinct Oregon statute.
Can an Oregon telehealth provider legally prescribe compounded semaglutide or BPC-157?
A telehealth provider in Oregon can prescribe FDA-approved semaglutide/tirzepatide products through a licensed pharmacy, but Oregon Board of Pharmacy guidance warns that compounding these GLP-1 drugs outside FDA/USP-compliant sourcing can trigger enforcement, and BPC-157 cannot be legally compounded or prescribed at all following the FDA's nationwide compounding ban on that peptide. [5]
What happens if an Oregon pharmacy compounds peptides that don't meet federal or state rules?
The Oregon Board of Pharmacy has stated that compounding semaglutide or other GLP-1 drug products in a way that fails to conform with governing law, or dispensing such products, may lead to Board enforcement action against the pharmacy's license. [5]
Does Oregon have its own "research chemical" law separate from federal drug law for peptides?
No—repeated searches of Oregon statutes, Board of Pharmacy rules, position statements, and legislative bill-tracking databases found no Oregon-specific law naming peptides or "research chemicals" as a distinct legal category, so peptide legality in Oregon defaults to general state pharmacy/compounding law plus federal FDA drug law. [1]